Article
Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations.
Marine drugs - 25 Jun 2021
Katz Dana, DiMattia Michael A, Sindhikara Dan, Li Hubert, Abraham Nikita, Leffler Abba E
Abstract excerpt
Nicotinic acetylcholine receptor (nAChR) subtypes are key drug targets, but it is challenging to pharmacologically differentiate between them because of their highly similar sequence identities. Furthermore, α-conotoxins (α-CTXs) are naturally selective and competitive antagonists for nAChRs and hold great potential for treating nAChR disorders. Identifying selectivity-enhancing mutations is the chief aim of most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
